Cargando…
Fahr’s syndrome: literature review of current evidence
Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cereb...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853434/ https://www.ncbi.nlm.nih.gov/pubmed/24098952 http://dx.doi.org/10.1186/1750-1172-8-156 |
_version_ | 1782294632268300288 |
---|---|
author | Saleem, Shafaq Aslam, Hafiz Muhammad Anwar, Maheen Anwar, Shahzad Saleem, Maria Saleem, Anum Rehmani, Muhammad Asim Khan |
author_facet | Saleem, Shafaq Aslam, Hafiz Muhammad Anwar, Maheen Anwar, Shahzad Saleem, Maria Saleem, Anum Rehmani, Muhammad Asim Khan |
author_sort | Saleem, Shafaq |
collection | PubMed |
description | Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cerebral cortex, Cerebellar Subcortical white matter and Dentate Nucleus. Molecular genetics of this disease haven’t been studied extensively; hence evidence at the molecular and genetic level is limited. Fahr’s disease commonly affects young to middle aged adults. Etiology of this syndrome does not identify a specific agent but associations with a number of conditions have been noted; most common of which are endocrine disorders, mitochondrial myopathies, dermatological abnormalities and infectious diseases. Clinical manifestations of this disease incorporate a wide variety of symptoms, ranging from neurological symptoms of extrapyramidal system to neuropsychiatric abnormalities of memory and concentration to movement disorders including Parkinsonism, chorea and tremors amongst others. Diagnostic criteria for this disease has been formulated after modifications from previous evidence and can be stated briefly, it consist of bilateral calcification of basal ganglia, progressive neurologic dysfunction, absence of biochemical abnormalities, absence of an infectious, traumatic or toxic cause and a significant family history. Imaging modalities for the diagnosis include CT, MRI, and plain radiography of skull. Other investigations include blood and urine testing for hematologic and biochemical indices. Disease is as yet incurable but management and treatment strategies mainly focus on symptomatic relief and eradication of causative factors; however certain evidence is present to suggest that early diagnosis and treatment can reverse the calcification process leading to complete recovery of mental functions. Families with a known history of Fahr’s disease should be counseled prior to conception so that the birth of affected babies can be prevented. This review was written with the aim to remark on the current substantial evidence surrounding this disease. |
format | Online Article Text |
id | pubmed-3853434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38534342013-12-07 Fahr’s syndrome: literature review of current evidence Saleem, Shafaq Aslam, Hafiz Muhammad Anwar, Maheen Anwar, Shahzad Saleem, Maria Saleem, Anum Rehmani, Muhammad Asim Khan Orphanet J Rare Dis Review Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cerebral cortex, Cerebellar Subcortical white matter and Dentate Nucleus. Molecular genetics of this disease haven’t been studied extensively; hence evidence at the molecular and genetic level is limited. Fahr’s disease commonly affects young to middle aged adults. Etiology of this syndrome does not identify a specific agent but associations with a number of conditions have been noted; most common of which are endocrine disorders, mitochondrial myopathies, dermatological abnormalities and infectious diseases. Clinical manifestations of this disease incorporate a wide variety of symptoms, ranging from neurological symptoms of extrapyramidal system to neuropsychiatric abnormalities of memory and concentration to movement disorders including Parkinsonism, chorea and tremors amongst others. Diagnostic criteria for this disease has been formulated after modifications from previous evidence and can be stated briefly, it consist of bilateral calcification of basal ganglia, progressive neurologic dysfunction, absence of biochemical abnormalities, absence of an infectious, traumatic or toxic cause and a significant family history. Imaging modalities for the diagnosis include CT, MRI, and plain radiography of skull. Other investigations include blood and urine testing for hematologic and biochemical indices. Disease is as yet incurable but management and treatment strategies mainly focus on symptomatic relief and eradication of causative factors; however certain evidence is present to suggest that early diagnosis and treatment can reverse the calcification process leading to complete recovery of mental functions. Families with a known history of Fahr’s disease should be counseled prior to conception so that the birth of affected babies can be prevented. This review was written with the aim to remark on the current substantial evidence surrounding this disease. BioMed Central 2013-10-08 /pmc/articles/PMC3853434/ /pubmed/24098952 http://dx.doi.org/10.1186/1750-1172-8-156 Text en Copyright © 2013 saleem et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Saleem, Shafaq Aslam, Hafiz Muhammad Anwar, Maheen Anwar, Shahzad Saleem, Maria Saleem, Anum Rehmani, Muhammad Asim Khan Fahr’s syndrome: literature review of current evidence |
title | Fahr’s syndrome: literature review of current evidence |
title_full | Fahr’s syndrome: literature review of current evidence |
title_fullStr | Fahr’s syndrome: literature review of current evidence |
title_full_unstemmed | Fahr’s syndrome: literature review of current evidence |
title_short | Fahr’s syndrome: literature review of current evidence |
title_sort | fahr’s syndrome: literature review of current evidence |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853434/ https://www.ncbi.nlm.nih.gov/pubmed/24098952 http://dx.doi.org/10.1186/1750-1172-8-156 |
work_keys_str_mv | AT saleemshafaq fahrssyndromeliteraturereviewofcurrentevidence AT aslamhafizmuhammad fahrssyndromeliteraturereviewofcurrentevidence AT anwarmaheen fahrssyndromeliteraturereviewofcurrentevidence AT anwarshahzad fahrssyndromeliteraturereviewofcurrentevidence AT saleemmaria fahrssyndromeliteraturereviewofcurrentevidence AT saleemanum fahrssyndromeliteraturereviewofcurrentevidence AT rehmanimuhammadasimkhan fahrssyndromeliteraturereviewofcurrentevidence |